Pfizer selects Concur Technologies for global deployment of T&E Expense management solution

Concur Expense, a Web-based T&E expense management solution, is designed to allow companies to focus on their core competencies and provides rapid return on investment.



Concur Expense, a Web-based T&E expense management solution, is designed to allow companies to focus on their core competencies and provides rapid return on investment.

"Companies are wise to look at corporate expenses as a way to cut costs
and increase efficiencies in a slowing economy," said Phil Dunphy, Senior
Manager of Global Travel for Pfizer. "We deployed all US employees on Concur
Expense, and based on the success of that project, we chose to expand our
license with Concur for worldwide deployment. Pfizer will achieve significant
T&E savings as a result of our worldwide deployment of Concur Expense."

"Pfizer is at the forefront of companies who have recognized the importance of reducing corporate expenses in the slowing economy," said Steve Singh, Chairman, President and CEO for Concur. "Pfizer's selection of our market-leading expense management solution for worldwide deployment is a tremendous validation for our ability to deliver global deployments that achieve rapid return on investment. Our unmatched experience in deploying tens of thousands to hundreds of thousands of
employees in large corporations, like Pfizer, is what makes Concur uniquely
qualified to meet Pfizer's worldwide expense management needs."

According to its developers, the Concur Expense solution is designed to automate each step of the T&E expense management process, from expense report preparation and approval, to policy compliance, data analysis and reimbursement.